$22.13+1.51% · 3M
Moving avg
1W-15.60%
1M-11.97%
3M+1.51%
6M-13.92%
YTD-1.73%
1Y+26.97%
3Y+84.42%
5Y-26.62%
52-week range
$13.3961% of range$27.72
Company health
Value2/6
Growth4/6
Profitability2/6
Health3/6
Dividend0/6
Bull vs bear
Strengths
- Analysts see 30% upside to a $29 target
- Analyst consensus is "Buy"
Risks
- Currently unprofitable
- More volatile than the market (beta 1.7)
Key statistics
Valuation
Market cap
$11.05B
Enterprise value
$16.21B
P/E ratio (TTM)
-50.86x
P/S ratio (TTM)
2.58x
EV/EBITDA
21.22x
Per share & returns
EPS (TTM)
-$0.49
Dividend yield
0.00%
Beta (1Y)
1.69
30-day change
-11.97%
Trading
Volume (24h)
6.89M
Previous close
$22.73
Shares outstanding
499.45M
About Elanco Animal Health Incorporated
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Symbol
ELAN
Elanco Animal Health Incorporated is a large-cap healthcare company in the Drug Manufacturers - Specialty & Generic industry. Its shares are listed on NYSE (United States) and trade under the ticker ELAN.
Frequently asked questions
What is Elanco Animal Health Incorporated's market cap?
Elanco Animal Health Incorporated (ELAN) has a market capitalization of $11.05B.
What sector is Elanco Animal Health Incorporated in?
Elanco Animal Health Incorporated operates in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.
What exchange does ELAN trade on?
ELAN trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.56B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.12B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap